Drug repurposing unveils new combinatorial treatments to treat mutant KRAS lung cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
We report data on a drug combination with synergistic antitumor effect in KRAS-driven lung cancer. We used RNAseq to characterize the transcriptional changes elicited by each drug in a mutant KRAS lung cancer cell lines (H1792) H1792 cell line treated with Trametinib (MEKi) or Lestaurtinib (multikinase FLT3i) for 16 hours
创建时间：
2023-11-10
